Overview

Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment

Status:
Completed
Trial end date:
2005-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if the combination of chemotherapy drugs and drugs to suppress testosterone (hormone therapy) is effective in controlling early prostate cancer. This study will attempt to: - stop or slow the growth of disease - gain information about prostate cancer - evaluate the effectiveness and side effects of the study drug
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Treatments:
Androgens
Bicalutamide
Docetaxel
Estramustine
Goserelin